Contineum Therapeutics
$13.44
1
-$0.01-0.07% Thursday 20:00
Statistics
Day High
14.06
Day Low
13.14
52W High
16.33
52W Low
3.35
Volume
110,784
Avg. Volume
289,278
Mkt Cap
392.21M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
14MayExpected
Expected EPS
-0.531429
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-84.52MNet Income
Analyst Ratings
$18.67Average Price Target
The highest estimate is 22.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 67%
Hold 33%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CTNM. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. Its lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis and progressive multiple sclerosis (MS). The company also develops PIPE-307, a novel, small molecule selective inhibitor of the muscarinic type 1 M1 receptor to treat depression and relapse remitting MS; and CTX-343, a peripherally-restricted LPA1R antagonist. Contineum Therapeutics, Inc. was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November 2023. The company was incorporated in 2009 and is headquartered in San Diego, California.
Show more...
CEO
Mr. Carmine N. Stengone MBA, MS
Employees
41
Country
US
ISIN
US21217B1008
Listings
0 Comments
Share your thoughts
FAQ
What is Contineum Therapeutics stock price today?▼
The current price of CTNM is $13.44 USD — it has decreased by -0.07% in the past 24 hours. Watch Contineum Therapeutics stock price performance more closely on the chart.
What is Contineum Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Contineum Therapeutics stocks are traded under the ticker CTNM.
Is Contineum Therapeutics stock price growing?▼
CTNM stock has risen by +0.75% compared to the previous week, the month change is a -9.56% fall, over the last year Contineum Therapeutics has showed a +131.72% increase.
What is Contineum Therapeutics market cap?▼
Today Contineum Therapeutics has the market capitalization of 392.21M
When is the next Contineum Therapeutics earnings date?▼
Contineum Therapeutics is going to release the next earnings report on May 14, 2026.
What were Contineum Therapeutics earnings last quarter?▼
CTNM earnings for the last quarter are -0.49 USD per share, whereas the estimation was -0.39 USD resulting in a -26.03% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Contineum Therapeutics revenue for the last year?▼
Contineum Therapeutics revenue for the last year amounts to 0 USD.
What is Contineum Therapeutics net income for the last year?▼
CTNM net income for the last year is -84.52M USD.
How many employees does Contineum Therapeutics have?▼
As of April 04, 2026, the company has 41 employees.
In which sector is Contineum Therapeutics located?▼
Contineum Therapeutics operates in the Health Care sector.
When did Contineum Therapeutics complete a stock split?▼
Contineum Therapeutics has not had any recent stock splits.
Where is Contineum Therapeutics headquartered?▼
Contineum Therapeutics is headquartered in San Diego, US.